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The CIAOW study (Complicated intra-abdominal infections worldwide observational study) is a multicenter observational
study underwent in 68 medical institutions worldwide during a six-month study period (October 2012-March 2013).
The study included patients older than 18 years undergoing surgery or interventional drainage to address complicated
intra-abdominal infections (IAIs).
1898 patients with a mean age of 51.6 years (range 18-99) were enrolled in the study. 777 patients (41%) were women
and 1,121 (59%) were men. Among these patients, 1,645 (86.7%) were affected by community-acquired IAIs while the
remaining 253 (13.3%) suffered from healthcare-associated infections. Intraperitoneal specimens were collected from
1,190 (62.7%) of the enrolled patients.
827 patients (43.6%) were affected by generalized peritonitis while 1071 (56.4%) suffered from localized peritonitis or
abscesses.
The overall mortality rate was 10.5% (199/1898).
According to stepwise multivariate analysis (PR = 0.005 and PE = 0.001), several criteria were found to be independent
variables predictive of mortality, including patient age (OR = 1.1; 95%CI = 1.0-1.1; p < 0.0001), the presence of small
bowel perforation (OR = 2.8; 95%CI = 1.5-5.3; p < 0.0001), a delayed initial intervention (a delay exceeding 24 hours)
(OR = 1.8; 95%CI = 1.5-3.7; p < 0.0001), ICU admission (OR = 5.9; 95%CI = 3.6-9.5; p < 0.0001) and patient immunosuppression
(OR = 3.8; 95%CI = 2.1-6.7; p < 0.0001).* Correspondence: massimosartelli@gmail.com
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Intra-abdominal infections (IAIs) include a wide spectrum
of pathological conditions, ranging from uncomplicated
appendicitis to faecal peritonitis [1].
In the event of complicated IAI the infection proceeds
beyond a singularly affected organ and causes either lo-
calized peritonitis (intra-abdominal abscesses) or diffuse
peritonitis. Effectively treating patients with complicated
intra-abdominal infections involves both source control
and antimicrobial therapy [2,3].
In order to describe the epidemiological, clinical,
microbiological, and surgical treatment profiles of com-
plicated intra-abdominal infections (IAIs) in Europe, the
World Society of Emergency Surgery (WSES) designed
the CIAO Study (Complicated intra-abdominal infections
observational study). The CIAO Study was conducted
during 2012 across twenty European countries [4].
Given the interesting results of the CIAO Study, WSES
designed a prospective observational study investigating
the management of complicated intra-abdominal infec-
tions in a worldwide context.
The CIAOW study (Complicated intra-abdominal in-
fections worldwide observational study) is a multicenter
observational study underwent in 68 medical institutions
worldwide during a six-month study period (October
2012-March 2013).
In January 2013 the preliminary results (2-month
study period) of the CIAOW study were published [5].
WSES presents the definitive data of the CIAOW
Study.
Methods
Aim
The purpose of the study was to describe the clinical,
microbiological, and treatment profiles of both community-
and healthcare-acquired complicated IAIs in a worldwide
context.Figure 1 Participating centers for each continent.Patients older than 18 years with both community-
acquired and healthcare-associated IAIs were included
in the database.
Study population
The CIAOW study is a multicenter observational study
underwent in 68 medical institutions worldwide. The
study included patients undergoing surgery or interven-
tional drainage to address complicated IAIs.
Medical institutions from each continent participated
in the study. The geographical distribution of the partici-
pating centers are represented in Figure 1.
Study design
The study did not attempt to change or modify the la-
boratory or clinical practices of the participating physi-
cians, and neither informed consent nor formal approval
by an Ethics Committee were required.
The study met the standards outlined in the Declar-
ation of Helsinki and Good Epidemiological Practices.
The study was monitored by the coordination center,
which investigated and verified missing or unclear data
submitted to the central database. This study was per-
formed under the direct supervision of the board of di-
rectors of WSES.
Data collection
In each centre, the coordinator collected and compiled
data in an online case report system. These data included
the following: (i) patient and disease characteristics, i.e.,
demographic data, type of infection (community- or
healthcare-acquired), severity criteria, previous curative
antibiotic therapy administered in the 7 days preceding
surgery; (ii) origin of infection and surgical procedures
performed; and (iii) microbiological data, i.e., identification
of bacteria and microbial pathogens within the peritoneal
Table 1 Clinical findings
Clinical findings Patients
N 1898 (100%)
Abdominal pain 288 (15.1)
Abdominal pain, abdominal rigidity 284 (15%)
Abdominal pain, abdominal rigidity, T > 38°C
or <36°C, WBC >12,000 or < 4,000
314 (16.5%)
Abdominal pain, abdominal rigidity, T > 38°C or <36°C, 67 (3.5)
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biotic susceptibilities of bacterial isolates.
The primary endpoints included the following:
 Clinical profiles of intra-abdominal infections
 Epidemiological profiles (epidemiology of the
microorganisms isolated from intra-abdominal
samples and these organisms’ resistance to antibiotics)
 Management profiles
Abdominal pain, abdominal rigidity, WBC >12,000
or < 4,000
376 (19.8%)
Abdominal pain, T > 38°C or <36°C, 68 (3.6%)
Abdominal pain, T > 38°C or <36°C, WBC >12,000
or < 4,000
139 (7.3%)
Abdominal pain, WBC >12,000 or < 4,000 266 (14%)
T > 38°C or <36°C 6 (0.3%)
T > 38°C or <36°C, WBC >12,000 or < 4,000 12 (0.6%)
Abdominal rigidity, WBC >12,000 or < 4,000 9 (0.5%)
Abdominal rigidity 2 (0.1%)
Abdominal rigidity, T > 38°C or <36°C 1 (0.05%)
Abdominal pain, abdominal rigidity, T > 38°C
or <36°C, WBC >12,000 or < 4,000
7 (0.4%)
WBC >12,000 or < 4,000 11 (0.6%)
Not reported 48 (2.5%)Results
Patients
2,020 cases were collected in the online case report sys-
tem. 122 cases did not meet the inclusion criteria.
1,898 patients with a mean age of 51.6 years (range
18-99) were enrolled in the CIAOW study. 777 patients
(41%) were women and 1,121 (59%) were men. Among
these patients, 1,645 (86.7%) were affected by community-
acquired IAIs while the remaining 253 (13.3%) suffered
from heathcare-associated infections. Intraperitoneal spec-
imens were collected from 1,190 (62.7%) of the enrolled
patients [213 patients (84.2%) with Healthcare-associated
infections and 977 (59.4%) with Community-acquired
infections].
827 patients (43.6%) were affected by generalized peri-
tonitis while 1071 (56.4%) suffered from localized peri-
tonitis or abscesses.
296 patients (14.2%) were admitted in critical condi-
tion (severe sepsis/septic shock).
Table 1, 2 overview the clinical findings and radio-
logical assessments recorded upon patient admission.Table 2 Radiological procedures
Radiological procedures Patients
N 1898 (100%)
Abdomen X ray 240 (12.6%)
Abdomen X ray, CT 102 (5.4%)
Abdomen X ray, ultrasound 356 (18.7%)
Abdomen X ray, ultrasound, CT 112 (5.9%)
Abdomen X ray, ultrasound, MRI 4 (0.2%)
Abdomen X ray, CT,ultrasound, MRI 7 (0.4%)
CT 426 (22.4%)
CT, MRI 2 (0.1%)
Ultrasound 384 (20.2%)
Ultrasound, CT 87 (4.6%)
Ultrasound, CT, MRI 1 (0.05%)
Ultrasound, MRI 3 (0.1%)
MRI 1 (0.05%)
Not reported 173 (9.1%)Source control
The various sources of infection are outlined in Table 3.
The most frequent source of infection was acute appendi-
citis; 633 cases (33.3%) involved complicated appendicitis.
The open appendectomy was the most common
means of addressing complicated appendicitis. 358 pa-
tients (56.5%) admitted for complicated appendicitis
underwent open appendectomies: 276 patients (77.1%)
for localized infection or abscesses and 82 patients
(22.9%) for generalized peritonitis. A laparoscopic ap-
pendectomy was performed for 226 patients (35.7%)
with complicated acute appendicitis; of these patients,
193 (85.4%) underwent the procedure for localized peri-
tonitis/abscesses and 33 (14.6%) underwent the proced-
ure for generalized peritonitis.
Open bowel resection was performed for 5 patients af-
fected by complicated appendicitis. In the other 48 cases
of complicated appendicitis (7.6%), conservative treat-
ment (percutaneous drainage, surgical drainage, and
non-operative treatment) was performed. 3% of patients
underwent percutaneous drainage (17/513) to addressappendicular abscesses or localized intra-abdominal
infections.
Among the patients with complicated cholecystitis
(278), the open cholecystectomy was the most frequently
performed procedure. 47.8% (133) and % 36.7 (102) of
cholecystitis patients underwent open and laparoscopic
Table 3 Source of infection
Source of infection Patients
N 1898 (100%)
Appendicitis 633 (33.3%)
Cholecystitis 278 (14.6%)
Post-operative 170 (15.,9%)
Colonic non diverticular perforation 115 (9.9%)
Gastroduodenal perforations 253 (13.3%)
Diverticulitis 106 (5.6%)
Small bowel perforation 145 (7.6%)
Others 122 (6.4%)
PID 30 (1.6%)
Post traumatic perforation 46 (2.4%)
Table 4 Aerobic bacteria identified from intra-operative
peritoneal fluid
Total 1.330 (100%)
Aerobic Gram-negative bacteria 957 (71.9%)
Escherichia coli 548 (41.2%)
(Escherichia coli resistant to third generation
cephalosporins)
75 (5.6%)
Klebsiella pneuumoniae 140 (10.5%)
(Klebsiella pneumoniae resistant to third
generation cephalosporins)
26 (1.4%)
Klebsiella oxytoca 11 (0.8%)
(Klebsiella oxytoca resistant to third generation
cephalosporins)
2 (0.1)
Enterobacter 64 (4.8%)
Proteus 47 (3.5%)
Pseudomonas 74 (5.6%)
Others 73 (5.6%)
Aerobic Gram-positive bacteria 373 (29.1%)
Enterococcus faecalis 153 (11.5%)
Enterococcus faecium 58 (4.4%)
Staphylococcus Aureus 38 (2.8%)
Streptococcus spp. 85 (6,4%)
Others 39 (2.9%)
Sartelli et al. World Journal of Emergency Surgery 2014, 9:37 Page 4 of 10
http://www.wjes.org/content/9/1/37cholecystectomies, respectively. The remaining patients
were treated with conservative methods (percutaneous
drainage, non-operative treatment).
Among the patients with complicated diverticulitis
(106) the Hartmann resection was the most frequently
performed procedure. 48 patients (45.3%) underwent a
Hartmann resection. 31 of these patients (64.6%) under-
went a Hartmann resection for generalized peritonitis,
while the remaining 17 (35.6%) underwent the same pro-
cedure for localized peritonitis or abscesses. Colo-rectal
resection was performed in 18 cases (17%) (5 with and
13 without protective stoma).
The remaining patients received conservative treat-
ment (percutaneous drainage, non-operative treatment,
surgical drainage and stoma). 4 patients underwent lap-
aroscopic drainage.
For patients with gastro-duodenal perforations (253
cases), the most common surgical procedure was gastro-
duodenal suture. 212 patients underwent open gastro-
duodenal suture (83.8%) and 18 patients underwent
laparoscopic gastro-duodenal suture (7.1%). 12 patients
(4.7%) underwent gastro-duodenal resection and 6 patients
(2.4%) received conservative treatment. The remaining pa-
tients underwent alternative procedures.
Of the 145 patients with small bowel perforations, 98
underwent open small bowel resection (85.2%) and 3
(2%) underwent laparoscopic small bowel resection. 28
patients (19.3%) were treated by stoma.
Among the 115 patients with colonic non-diverticular
perforation, 42 (36.5%) underwent Hartmann resection,
26 (22.6%) underwent open resection with anastomosis
and without stoma protection, and 26 underwent open
resection with stoma protection (22.6%).
170 cases (8.9%) were attributable to post-operative
infections.
Source control was successfully implemented for 1,735
patients (91.4%).Microbiology
Intraperitoneal specimens were collected from 1,190 pa-
tients (62.7%).
These specimens were obtained from 977 of the 1,645
patients presenting with community-acquired intra-
abdominal infections (59.4%).
Intraperitoneal specimens were collected from 213
(84.2%) of the remaining 253 patients with nosocomial
intra-abdominal infections.
The aerobic bacteria identified in intraoperative sam-
ples are reported In Table 4, 5.
The microorganisms isolated in subsequent samples
from peritoneal fluid are reported in Table 6.
All the microorganisms isolated in both intraoperative
and subsequent samples from peritoneal fluid are re-
ported in Table 7.
The major pathogens involved in intra-abdominal in-
fections were found to be Enterobacteriaceae.
Among the intra-operative isolates, Extended-Spectrum
Beta-Lactamase (ESBL)-producing Escherichia coli isolates
comprised 13.7% (75/548) of all Escherichia coli isolates,
while ESBL-positive Klebsiella pneumoniae isolates repre-
sented 18.6% (26/140) of all Klebsiella pneumoniae
isolates. ESBL-positive Enterobacteriaceae were more
prevalent in patients with healthcare associated infections
IAIs than they were in patients with community-acquired
IAIs. ESBL-positive Escherichia coli isolates comprised
Table 5 Aerobic bacteria from intra-operative samples in both community-acquired and healthcare-associated IAIs
Community-acquired IAIs Isolates n° Healthcare-associated (nosocomial) IAIs Isolates n°
Aerobic bacteria 1030 (100%) Aerobic bacteria 300 (100%)
Escherichia coli 456 (44.3%) Escherichia coli 92 (21%)
(Escherichia coli resistant to third generation
cephalosporins)
56 (5.4%) (Escherichia coli resistant to third generation
cephalosporins)
19 (6.3%)
Klebsiella pneumoniae 105 (10.1%) Klebsiella pneumoniae 35 (11.7%)
(Klebsiella pneumoniae resistant to third generation
cephalosporins)
11 (0.1%) (Klebsiella pneumoniae resistant to third generation
cephalosporins)
15 (5%)
Pseudomonas 56 (5.4%) Pseudomonas 18 (5.7%)
Enterococcus faecalis 106 (10.3%) Enterococcus faecalis 47 (15.7%)
Enterococcus faecium 38 (3.7%) Enterococcus faecium 20 (6.7%)
Table 7 Total of microorganisms identified from both
intraoperative and subsequent peritoneal samples
Total 1826 (100%)
Aerobic Gram-negative bacteria 1152 (63%)
Escherichia coli 653 (35.7%)
(Escherichia coli resistant to third generation
cephalosporins)
110 (6%)
Klebsiella pneuumoniae 181 (9.9%)
(Klebsiella pneumoniae resistant to third
generation cephalosporins)
39 (2.1%)
Klebsiella oxytoca 11 (0.6%)
(Klebsiella oxytoca resistant to third generation
cephalosporins)
2 (0.1)
Sartelli et al. World Journal of Emergency Surgery 2014, 9:37 Page 5 of 10
http://www.wjes.org/content/9/1/3720.6% (19/92) of all identified Escherichia coli isolates,
while ESBL-positive Klebsiella pneumoniae isolates made
up 42.8% (15/35) of all identified Klebsiella pneumoniae
isolates.
Among all the microorganisms isolated in both intra-
operative and subsequent samples from peritoneal fluid,
there were 110 isolates of Escherichia coli ESBL, 39 iso-
lates of Klebsiella pneumoniae ESBL, 2 isolates of Klebsi-
ella Oxytoca ESBL. There were 5 isolates of Klebsiella
pneumoniae resistant to Carbapenems.
Among the microorganisms isolated in the intraopera-
tive samples, there were 74 isolates of Pseudomonas
aeruginosa, comprising 5.6% of all aerobic identified bac-
teria isolates.Table 6 Microorganisms identified from subsequent
peritoneal samples
Total 268 (100%)
Aerobic Gram-negative bacteria 195 (72.7%)
Escherichia coli 105 (41.8%)
(Escherichia coli resistant to third generation
cephalosporins)
35 (13.%)
Klebsiella pneuumoniae 41 (15.3%)
(Klebsiella pneumoniae resistant to third
generation cephalosporins)
13 (4.8%)
Pseudomonas 20 (7.4%)
Others 29 (10.8%)
Aerobic Gram-positive bacteria 41 (15.3%)
Enterococcus faecalis 16 (6%)
Enterococcus faecium 10 (3.4%)
Staphylococcus Aureus 7 (4%)
Others 8 (3%)
Bacteroides 8 (3%)
Candida albicans 17 (6%)
Non candida albicans 6 (2.2%)
Other yeats 2 (0.7%)
Enterobacter 75 (4.1%)
Proteus 52 (2.8%)
Pseudomonas 94 (5.1%)
Others 102 (5.6%)
Aerobic Gram-positive bacteria 414 (22.7%)
Enterococcus faecalis 169 (9.2%)
Enterococcus faecium 68 (3.7%)
Staphylococcus Aureus 46 (2.5%)
Streptococcus spp. 85 (4.6%)
Others 47 (2.6%)
Anaerobes 141 (7.7%)
Bacteroides 108 (5.9%)
(Bacteroides resistant to Metronidazole) 3 (0.2%)
Clostridium 11 (0.6%)
Others 22 (1.2%)
Candida spp. 117 (6.4%)
Candida albicans 90 (4.9%)
(Candida albicans resistant to Fluconazole) 2 (0.1%)
Non-albicans Candida 27 (1.4%)
(non-albicans Candida resistant to Fluconazole) 3 (0.1%)
Other yeats 2 (0.1%)
Table 9 Candida isolates identified from intra-operative
peritoneal fluid
Candida spp. 94
Candida albicans 73 (78.7%)
(Candida albicans resistant to Fluconazole) 2 (2.1%)
Non-albicans Candida 21 (19.1%)
(non-albicans Candida resistant to Fluconazole) 3 (3.2%)
Table 10 Univariate analysis: risk factors for occurrence
of death during hospitalization
Risk factors Odds ratio 95%CI p
Clinical condition upon hospital
admission
Severe sepsis 27.6 15.9-47.8 <0.0001
Septic shock 14.6 8.7-24.4 <0.0001
Healthcare associated infection 3.1 2.2-4.5 <0.0001
Source of infection
Colonic non-diverticular perforation 21 9.9-44.6 <0.0001
Small bowel perforation 125.7 29.1-542 <0.0001
Complicated diverticulitis 11 4.9-25.2 <0.0001
Post-operative infections 19.1 9.3-39.3 <0.0001
Delayed initial intervention 2.6 1.8-3.5 <0.0001
Immediate post-operative
clinical course
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operative and subsequent samples from peritoneal fluid,
there were 94 isolates of Pseudomonas aeruginosa, com-
prising 5.1% of all identified bacteria isolates.
The 2 Pseudomonas aeruginosa strains resistant to Car-
bapenems were also obtained from nosocomial infections.
Among all the aerobic gram-positive bacteria identified
in the intraoperative samples, Enterococci (E. faecalis
and E. faecium) were the most prevalent, representing
15.9% of all aerobic isolates, and were identified in
211 cases. Although Enterococci were also present in
community-acquired infections, they were more prevalent
in healthcare-associated infections (31.7%: 67/211).
Among all the microorganisms isolated in both intra-
operative and subsequent samples from peritoneal fluid
Enterococci were 237/1826 (12.9%).
11 glycopeptide-resistant Enterococci were identified; 5
were glycopeptide-resistant Enterococcus faecalis isolates
and 6 were glycopeptide-resistant Enterococcus faecium
isolates.
Tests for anaerobes were conducted for 486 patients.
Identified anaerobic bacteria from intra-operative speci-
mens are reported in Table 8.
Among all the microorganisms isolated in both intra-
operative and subsequent samples from peritoneal fluid,
141 anaerobes were observed. The most frequently iden-
tified anaerobic pathogen was Bacteroides. 108 Bacter-
oides isolates were observed during the course of the
study.
In Table 9 are illustrated Candida spp. isolated in intra-
operative specimens.
Among all the microorganisms isolated in both intra-
operative and subsequent samples from peritoneal fluid,
117 Candida isolates were collectively identified (6%).
90 were Candida albicans and 27 were non-albicans
Candida.
Outcome
The overall mortality rate was 10.5% (199/1898).
565 patients (29.8%) were admitted to the intensive
care unit (ICU) in the early recovery phase immediately
following surgery.
223 patients (11.7%) ultimately required additional
surgeries. 62 (11.3%) of these patients underwent open
abdominal procedures.Table 8 Anaerobic bacteria identified from intra-operative
peritoneal fluid
Anaerobes 133
Bacteroides 100 (75%)
(Bacteroides resistant to Metronidazole) 3 (1.5%)
Clostridium 11 (8.2%)
Others 22 (16.5%)In the immediate post-operative clinical period 269 pa-
tients were critically ill (132 with septic shock, 137 with
severe sepsis).
According to univariate statistical analysis of the data
(Table 10), septic shock (OR = 14.9; 95%CI = 9.3-26.7; p <
0.0001) and severe sepsis (OR = 4.2; 95%CI = 2.8-6.3; p <
0.0001) upon hospital admission were both predictive of
patient mortality.
The setting of acquisition was also a variable found to
be predictive of patient mortality (healthcare-associated
infections: OR = 3.1; 95%CI = 2.2-4.5; p < 0.0001).
Among the various sources of infection, colonic non-
diverticular perforation (OR = 21; 95%CI = 9.9-44.6 p <
0.0001), complicated diverticulitis (OR = 11; 95%CI =
4.9-25.2; p < 0.0001), small bowel perforation (OR = 14.3;
95%CI = 6.7-30.3; p < 0.0001) and post-operative infec-
tions (OR = 19.1; 95%CI = 9.3-39.3; p < 0.0001) were sig-
nificantly correlated with patient mortality.Severe sepsis 33.8 19.5-58.4 <0.0001
Septic shock 59.2 34.4-102.1 <0.0001
ICU admission 18.6 12-28.7 <0.0001
Comorbidities
Malignancy 3.6 2.5-15.1 p < 0.0001
Immunosoppression 1.0 3.2-7.5 p < 0.0001
Serious cardiovascular disease 4.5 3.2-6.3 p < 0.0001
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degree between patients who received adequate source
control and those who did not. However, a delayed
initial intervention (a delay exceeding 24 hours) was as-
sociated with an increased mortality rate (OR = 3.6; 95%
CI = 1.9-3.7; p < 0.0001).
The nature of the immediate post-operative clinical
period was a significant predictor of mortality (severe
sepsis: OR = 10.5; 95%CI = 24.0-66.0; p < 0.0001, septic
shock: OR = 39.8; 95%CI = 6.4-17.5; p < 0.0001). Patients
requiring ICU admission (OR = 12.9; 95%CI = 8.8-19.0;
p < 0.0001) were also associated with increased mortality
rates.
Also comorbidities were associated to patient mortality
(Malignancy: OR = 3.6; 95%CI = 2.5-15.1; p < 0.0001, im-
munosuppression: OR = 1.0; 95%CI = 3.2-7.5; p < 0.0001,
and serious cardiovascular disease: OR = 4.5; 95%CI =
3.2-6.3, p < 0.0001).
According to stepwise multivariate analysis (PR = 0.005
and PE = 0.001) (Table 11), several criteria were found to
be independent variables predictive of mortality, includ-
ing patient age (OR = 1.1; 95%CI = 1.0-1.1; p < 0.0001),
the presence of small bowel perforation: OR = 2.8; 95%
CI = 1.5-5.3; p < 0.0001), a delayed initial intervention (a
delay exceeding 24 hours) (OR = 1.8; 95%CI = 1.5-3.7; p <
0.0001), ICU admission (OR = 5.9; 95%CI = 3.6-9.5; p <
0.0001) and patient immunosuppression (OR = 3.8; 95%
CI = 2.1-6.7; p < 0.0001).
Discussion
The CIAOW Study confirmed that acute appendicitis is
the most common intra-abdominal condition requiring
emergency surgery worldwide. According to the WSES
2013 guidelines for management of intra-abdominal in-
fections, both open and laparoscopic appendectomies
are viable treatment options for complicated appendicitis
[6]. CIAOW Study results indicate that the open ap-
proach was used in most patients and it was the most
common approach in the patients with complicated
appendicitis.
For patients with peri-appendiceal abscesses, the
proper course of surgical treatment remains a point ofTable 11 Multivariate analysis: risk factors for occurrence
of death during hospitalization
Risk factors Odds ratio 95%CI p
Age 3.3 2.2-5 <0.0001
Small bowel perforation 27.6 15.9-47.8 <0.0001
Delayed initial intervention 14.6 8.7-24.4 <0.0001
ICU admission 2.3 1.5-3.7 <0.0001
Immunosuppression 3.8 2.1-6.7 <0.0001
Stepwise multivariate analysis, PR = 0.005 E PE = 0.001 (Hosmer-Lemeshow chi2
(8) = 1.68, area under ROC curve = 0.9465).contention in the medical community. Although guide-
lines for the management of intra-abdominal infections
commonly assert that patients with peri-appendiceal
abscesses should be treated with percutaneous image-
guided drainage [5]. Percutaneous drainage with or with-
out interval appendectomy to treat peri-appendiceal
abscess results in fewer complications and shorter over-
all length of stay [6-8]. Data from CIAOW Study indi-
cate that few patients underwent this procedure for a
peri-appenceal abscess.
Laparoscopic cholecystectomy versus open cholecyst-
ectomy question for acute cholecystitis has been exten-
sively investigated. Several studies showed that early
laparoscopic cholecystectomy resulted in a significantly
reduced length of stay, no major complications, and no
significant difference in conversion rates when compared
with initial antibiotic treatment and delayed laparoscopic
cholecystectomy [9-12].
The open cholecystectomy was the most common
means of treating complicated cholecystitis; 47.8% (133)
of the patients with complicated cholecystitis underwent
this procedure. By contrast, 36.7% (102) underwent a
laparoscopic procedure.
The optimal surgical management of colonic diverticu-
lar disease complicated by peritonitis remains a contro-
versial issue. Hartmann’s resection has been considered
the procedure of choice in patients with generalized
peritonitis and remains a safe technique for emergency
colectomy in perforated diverticulitis, especially in elderly
patients with multiple co-morbidities [13]. More recently,
some reports have suggested that primary resection and
anastomosis is the preferred approach to diverticulitis,
even in the presence of diffuse peritonitis [14,15].
According to CIAOW Study data, the Hartmann resec-
tion was the most frequently performed procedure to ad-
dress both complicated diverticulitis and non-diverticular
colonic perforations worldwide.
The significance of microbiological analysis of infected
peritoneal fluid in community-acquired intra-abdominal
infections has been debated in recent years.
Although the absence of impact of bacteriological
cultures has been documented especially in appendi-
citis [16], in this era of the broad spread of resistant
microorganisms such as nosocomial and community
extended-spectrum b-lactamase (ESBL) Enterobacteria-
ceae, carbapenemase producing gram negatives, b lactam-
and vancomycin resistant enterococci (VRE), the threat of
resistance is a source of major concern for clinicians.
Therefore the results of the microbiological analyses have
great importance for the therapeutic strategy of every
patients.
According to CIAOW Study data, intraperitoneal
specimens were collected from 62.7% of patients with
complicated intra-abdominal infections.
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patients presenting with community-acquired intra-
abdominal infections.
Intraperitoneal specimens were collected from 84.2% of
the patients with nosocomial intra-abdominal infections.
In many clinical laboratories, species identification and
susceptibility testing of anaerobic isolates are not rou-
tinely performed. Tests for anaerobes were conducted
for 486 patients.
The major pathogens involved in community-acquired
intra-abdominal infections are Enterobacteriaceae, Strepto-
coccus species, and certain anaerobes (particularly B.
fragilis).
The main resistance threat in intra.-abdominal infec-
tions is posed by ESBL-producing Enterobacteriaceae,
which are becoming increasingly common in community-
acquired infections [17,18].
According to CIAOW Study data, ESBL producers
were the most commonly identified drug-resistant micro-
organism involved in IAIs.
Recent years have seen an escalating trend of Klebsi-
ella pneumoniae Carbapenemase (KPC) production,
which continues to cause serious multidrug-resistant in-
fections around the world. The recent emergence of
Carbapenem-resistant Enterobacteriaceae is a major
threat to hospitalized patients [19].
5 identified isolates of Klebsiella pneumoniae proved
resistant to Carbapenems.
Pseudomonas aeruginosa is one of the major nosoco-
mial pathogens worldwide. It is intrinsically resistant to
many drugs and is able to become resistant to virtually
any antimicrobial agent.
The rate of Pseudomonas aeruginosa was 5.6% of all
microorganisms isolated in the intra-operative samples.
According to CIAOW study there was no significant dif-
ference between community and healthcare associate
infections.
The 2 Pseudomonas aeruginosa strains resistant to Car-
bapenems were also obtained from nosocomial infections.
Enterococci are significant pathogens in intra-
abdominal infections. Among multidrug Gram positive
bacteria, Enterococci remain a challenge. The evolution of
antimicrobial resistance in these organisms poses enor-
mous challenges for clinicians when faced with patients
affected with Enterococcus infections. Enterococcus infec-
tions are difficult to treat because of both intrinsic and ac-
quired resistance to many antibiotics.
Enterococci (E. faecalis and E. faecium) were the most
common Gram positive aerobic isolates.
Although Enterococci were also identified in community-
acquired infections, they were far more prevalent in noso-
comial infections.
In the last years there has been a significant increase in
the incidence of invasive infections due to Candida species.Although the epidemiological role of Candida spp. in
nosocomial peritonitis is not yet defined, the clinical role
is significant, because Candida isolation is normally as-
sociated to a poor prognosis [20].
In the CIAOW Study 117 Candida isolates were col-
lectively identified (6%). 90 were Candida albicans and
27 were non-albicans Candida.
It is well known that patients with severe sepsis or
septic shock may be complicated by high mortality rates.
According to the CIAOW Study the overall mortality
rate was 10.5% (199/1898).
29.8% of patients were admitted to the ICU in the early
recovery phase immediately following surgery. In the im-
mediate post-operative clinical period 269 patients were
critically ill (132 with septic shock, 137 with severe sepsis).
The surgical treatment strategies following an initial
emergency laparotomy have been debated in the last
years.
The decision whether and when to perform a relapar-
otomy in secondary peritonitis is largely subjective and
based on professional experience. Factors indicative of
progressive or persistent organ failure during early post-
operative follow-up are the best indicators for ongoing
infection and associated positive findings at relaparot-
omy [21-23].
Relaparotomy strategies may include either a relapar-
otomy, when the patient's condition demands it ("rela-
parotomy on-demand"), or a planned relaparotomy with
temporarily abdomen closure or open abdomen [24-27].
In the CIAOW Study 223 post-operative patients
(11.7%) ultimately required additional surgeries. 62 (11.3%)
of these patients underwent open abdominal procedures.
According to univariate statistical analysis of the data,
septic shock and severe sepsis upon hospital admission
were both predictive of patient mortality.
The setting of acquisition was also a variable found to
be predictive of patient mortality (healthcare-associated
infections).
Among the various sources of infection, colonic non-
diverticular perforation, complicated diverticulitis, small
bowel perforation and post-operative infections were sig-
nificantly correlated with patient mortality.
Mortality rates did not vary to a statistically significant
degree between patients who received adequate source
control and those who did not. However, a delayed ini-
tial intervention (a delay exceeding 24 hours) was associ-
ated with an increased mortality rate.
The nature of the immediate post-operative clinical
period was a significant predictor of mortality. Patients
requiring ICU admission were also associated with in-
creased mortality rates.
Also comorbidities were associated to patient mortality.
According to stepwise multivariate analysis, several cri-
teria were found to be independent variables predictive of
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bowel perforation, a delayed initial intervention (a
delay exceeding 24 hours), ICU admission and patient
immunosuppression.
Conclusion
Complicated intra-abdominal infections remain an im-
portant source of patient morbidity and are frequently
associated with poor clinical prognoses, particularly for
patients in high-risk categories.
Given the sweeping geographical distribution of the
participating medical centers, the CIAOW Study gives
an accurate description of the epidemiological, clinical,
microbiological, and treatment profiles of complicated
intra-abdominal infections worldwide.
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